Edition:
United States

Accuray Inc (ARAY.OQ)

ARAY.OQ on NASDAQ Stock Exchange Global Select Market

5.22USD
23 Feb 2018
Change (% chg)

$0.17 (+3.47%)
Prev Close
$5.05
Open
$5.05
Day's High
$5.25
Day's Low
$5.03
Volume
85,965
Avg. Vol
205,441
52-wk High
$6.15
52-wk Low
$3.60

Chart for

About

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife... (more)

Overall

Beta: 1.79
Market Cap(Mil.): $445.66
Shares Outstanding(Mil.): 85.29
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.28 16.59
EPS (TTM): -- -- --
ROI: -- 9.69 35.07
ROE: -- 14.25 17.79

BRIEF-Accuray Retires February 2018 Convertible Notes

* ACCURAY RETIRES FEBRUARY 2018 CONVERTIBLE NOTES Source text for Eikon: Further company coverage:

Feb 05 2018

BUZZ-Accuray: RBC, Jefferies raise PTs after results

** Radiation and oncology device maker's shares up 7.69 pct at $5.6 premarket

Jan 24 2018

BRIEF-Accuray Reports Q2 Loss Per Share $0.06

* ACCURAY FISCAL SECOND QUARTER REVENUE EXCEEDS $100 MILLION AND INCREASES 15 PERCENT YEAR-OVER-YEAR; GROSS ORDERS OF $77.9 MILLION; BACKLOG UP 10 PERCENT

Jan 23 2018

BRIEF-Beverly Huss Joins Accuray Board Of Directors

* ACCURAY INC - WITH APPOINTMENT OF HUSS, CO'S BOARD CONSISTS OF SEVEN MEMBERS Source text for Eikon: Further company coverage:

Jan 11 2018

BRIEF-Accuray Elects Net Share Settlement For 3.50 Pct Series A Convertible Senior Notes

* ACCURAY ELECTS NET SHARE SETTLEMENT FOR 3.50% SERIES A CONVERTIBLE SENIOR NOTES DUE 2018

Jan 03 2018

BRIEF-Accuray Inc reports Q1 loss per share $0.11

* Accuray generated $55.6 million in first quarter gross orders; revenue increased 5 percent year over year

Oct 24 2017

Exclusive: Siemens mandates three banks for IPO of Healthineers unit - sources

FRANKFURT Germany's Siemens AG has mandated Goldman Sachs , Deutsche Bank and JP Morgan as lead organizers of an initial public offering (IPO) of its Healthineers unit, sources familiar with the matter said.

Oct 24 2017

BRIEF-European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

* European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

Oct 19 2017

Competitors

Earnings vs. Estimates